Literature DB >> 30395942

Co-activation of WT1 and AP-1 proteins on WT1 gene promoter to induce WT1 gene expression in K562 cells.

Songyot Anuchapreeda1, Methee Rungrojsakul2, Singkome Tima3, Sawitree Chiampanichayakul3, Sheryl R Krig4.   

Abstract

Earlier studies have revealed one function of the inhibitory mechanism of curcumin. Activating PKCα induces WT1 gene expression via signalling through downstream JNK and c-JUN. In the present study, the effect of c-JUN/AP-1 binding and transcriptional regulation of the WT1 gene promoter was investigated in K562 leukaemic cells. The non-cytotoxic dose (IC20 values) of curcumin (WT1 and AP-1 inhibitors) was employed to examine its effect on WT1 gene-mediated WT1 and AP-1 protein expression. Non-cytotoxic doses of both tanshinone IIA (AP-1 DNA-binding inhibitor) and SP600125 (JNK inhibitor) were used to test the role of c-JUN/AP-1 in WT1 gene expression. Curcumin, tanshinone IIA, and SP600125 inhibited WT1 protein expression in a dose-dependent manner (5-15 μM) at 24 h as shown by immunoblotting. A ChIP assay showed that curcumin and tanshinone IIA inhibited AP-1 and WT1 binding to the proximal WT1 promoter (-301 bp), and a luciferase reporter assay showed that the WT1 luciferase gene reporter activity was decreased after curcumin, tanshinone IIA, and SP600126 treatments. Furthermore, depletion of c-JUN abrogated WT1 gene expression. In summary, AP-1 contributes to the WT1 autoregulation of WT1 gene expression in leukaemic K562 cells.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  AP-1; JNK; K562; Leukaemia; Wilms' tumour 1; c-JUN

Mesh:

Substances:

Year:  2018        PMID: 30395942     DOI: 10.1016/j.cellsig.2018.11.001

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

1.  Sustained AWT1 expression by Dupuytren's disease myofibroblasts promotes a proinflammatory milieu.

Authors:  Johnny Luo; Trisiah Tugade; Emmy Sun; Ana Maria Pena Diaz; David B O'Gorman
Journal:  J Cell Commun Signal       Date:  2022-04-12       Impact factor: 5.782

2.  Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.

Authors:  Shanshan Wang; Yun Li; Wenzhi Li; Kun Zhang; Zhengqiang Yuan; Yina Cai; Kuncheng Xu; Jinrong Zhou; Zhiyun Du
Journal:  J Ethnopharmacol       Date:  2020-12-17       Impact factor: 5.195

3.  Cytotoxic and Antiproliferative Effects of Diarylheptanoids Isolated from Curcuma comosa Rhizomes on Leukaemic Cells.

Authors:  Natsima Viriyaadhammaa; Aroonchai Saiai; Waranya Neimkhum; Wariya Nirachonkul; Wantida Chaiyana; Sawitree Chiampanichayakul; Singkome Tima; Toyonobu Usuki; Suwit Duangmano; Songyot Anuchapreeda
Journal:  Molecules       Date:  2020-11-23       Impact factor: 4.411

4.  Antileukaemic Cell Proliferation and Cytotoxic Activity of Edible Golden Cordyceps (Cordyceps militaris) Extracts.

Authors:  Singkome Tima; Tawat Tapingkae; Chaiwat To-Anun; Parinn Noireung; Phikul Intaparn; Wantida Chaiyana; Jakkapan Sirithunyalug; Pawaret Panyajai; Natsima Viriyaadhammaa; Wariya Nirachonkul; Lapamas Rueankham; Win Lae Aung; Fah Chueahongthong; Sawitree Chiampanichayakul; Songyot Anuchapreeda
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-22       Impact factor: 2.650

5.  Antileukemic Cell Proliferation of Active Compounds from Kaffir Lime (Citrus hystrix) Leaves.

Authors:  Songyot Anuchapreeda; Fah Chueahongthong; Natsima Viriyaadhammaa; Pawaret Panyajai; Riki Anzawa; Singkome Tima; Chadarat Ampasavate; Aroonchai Saiai; Methee Rungrojsakul; Toyonobu Usuki; Siriporn Okonogi
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

6.  Psoralen inhibits the inflammatory response and mucus production in allergic rhinitis by inhibiting the activator protein 1 pathway and the downstream expression of cystatin‑SN.

Authors:  Wenying Gao; Zhenglong Jin; Yanxia Zheng; Youjia Xu
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.